WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Innoviva earnings were $357.2M for the trailing 12 months ending Jun 30, 2026, with 727.9% growth year over year. The latest INVA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$83.4M, down 144.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INVA reported annual earnings of $271.2M, with 1,059.2% growth. The next INVA earnings date is Nov 4, 2026.

INVA past earnings growth

How has INVA's earnings growth performed historically?

Company
727.87%
Industry
17.53%
Market
93.61%
INVA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INVA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INVA earnings history

Current Revenue
$440.0M
Current Earnings
$357.2M
Current Profit Margin
81.2%
INVA's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

INVA Return on Equity

Current Company
30%
Current Industry
-13.6%
Current Market
31.1%
INVA's Return on Equity (30%)... subscribe to Premium to read more.
High Return on Equity Performance

INVA Return on Assets

Current Company
21.6%
Current Industry
-10.2%
INVA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INVA announces earnings.

INVA Return on Capital Employed

Current Company
26.43%
Current Industry
-6.7%
INVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INVA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INVA$478.05M$357.24M+12.93%$5.05
AVLNN/AN/AN/AN/A
AAPGN/A-$218.69MN/A-$2.35
BCAX-$183.91M-$185.36MN/A-$3.10
LTGON/AN/AN/AN/A
View Top Biotech Stocks

INVA earnings dates

Next earnings date
Nov 4, 2026

Innoviva Earnings Reports & History FAQ

What were Innoviva's earnings last quarter?

On INVA's earnings call on Aug 5, 2026, Innoviva (NASDAQ: INVA) reported Q2 2026 earnings per share (EPS) of -$1.14, up 212.87% year over year. Total INVA earnings for the quarter were -$83.42 million. In the same quarter last year, Innoviva's earnings per share (EPS) was $1.01.

If you're new to stock investing, here's how to buy Innoviva stock.

When does Innoviva report earnings?

The next INVA earnings call is Nov 4, 2026. Add INVA to your watchlist to be reminded of Innoviva's next earnings date.

Is Innoviva profitable or losing money?

As of the last Innoviva earnings report, Innoviva is currently profitable. Innoviva's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $357.24 million, a 824.31% increase year over year.

What was INVA's earnings growth in the past year?

As of Innoviva's earnings date in Aug 5, 2026, Innoviva's earnings has grown 727.87% year over year. This is 710.34 percentage points higher than the US Biotechnology industry earnings growth rate of 17.53%. INVA earnings in the past year totalled $357.24 million.

What are Innoviva's earnings expectations?

The current EPS estimate for Innoviva's earnings report in Nov 4, 2026 is $0.50.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.